Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.

Autor: Asumda, Faizal Z.1 (AUTHOR) fasumda@augusta.edu, Campbell, Nellie A.2 (AUTHOR) campbell.nellie@mayo.edu, Hassan, Mohamed A.3 (AUTHOR), Fathi, Reza4 (AUTHOR) reza@redhillbio.com, Vasquez Rico, Daniella F.5 (AUTHOR) vasqu170@umn.edu, Kiem, Melanie2,6 (AUTHOR) moore.michael.j@wustl.edu, Vang, Ethan V.2 (AUTHOR) zhu.xinli@mayo.edu, Kim, Yo Han7 (AUTHOR) kim.yohan@mayo.edu, Luo, Xin8 (AUTHOR), O'Brien, Daniel R.9 (AUTHOR) obrien.daniel@mayo.edu, Buhrow, Sarah A.10 (AUTHOR) buhrow.sarah@mayo.edu, Reid, Joel M.10 (AUTHOR) reid@mayo.edu, Moore, Michael J.2 (AUTHOR), Ben-Yair, Vered Katz4 (AUTHOR) mark@redhillbio.com, Levitt, Mark L.4 (AUTHOR), Leiting, Jennifer L.11 (AUTHOR) leiting.jennifer@mayo.edu, Abdelrahman, Amro M.12 (AUTHOR) abdelrahman.amro@mayo.edu, Zhu, Xinli2,13 (AUTHOR), Lucien, Fabrice7 (AUTHOR) lucien-matteoni.fabrice@mayo.edu, Truty, Mark J.12 (AUTHOR) truty.mark@mayo.edu
Zdroj: Cancers. Mar2024, Vol. 16 Issue 5, p1050. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje